These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3284113)

  • 1. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the peroral absorption of the endekapeptide cyclosporine A.
    Ritschel WA; Ritschel GB; Sabouni A; Wolochuk D; Schroeder T
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):281-7. PubMed ID: 2755275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacoeconomic intrapatient comparison of Sandimmune capsules and Sandimmune oral solution in kidney transplant recipients.
    Dandavino R; Boucher A; Gagne M; Labelle B
    Transplant Proc; 1991 Feb; 23(1 Pt 2):985-6. PubMed ID: 1989353
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine pharmacokinetics in the early course of renal transplantation.
    Albrecht K; Niebel W; Marggraf G; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIA plasma cyclosporine values six hours after oral administration (T6)--an easy solution to a difficult therapeutic problem: a retrospective and prospective study.
    Cantarovich F; Bizollon C; Cantarovich D; Lefrancois N; Dubernard JM; Mizony Busnardo ME; De Arteaga J; Suso E; Mpio I; Traeger J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1723-5. PubMed ID: 3274415
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients.
    Zehnder C; Beveridge T; Nüesch E; Abisch A; Thiel G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):641-3. PubMed ID: 3284114
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of oral ciclosporin in the perioperative period after heart transplantation.
    Konertz W; Leimenstoll G; Weyand M; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):42-5. PubMed ID: 3067722
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements.
    Kohlhaw K; Wonigeit K; Frei U; Oldhafer K; Neumann K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):572-4. PubMed ID: 3284105
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of oral and intravenous cyclosporine A in kidney transplants.
    Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotransformation of cyclosporin G in comparison to cyclosporine.
    Mangold JB; Schran HF; Yatscoff RW; Weitzel WF; Leichtman AB
    Transplant Proc; 1994 Oct; 26(5):3013-6. PubMed ID: 7940950
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.
    Alexander DP; Horning L; Bowers LD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):499-508. PubMed ID: 3284097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 15. Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule.
    Bleck JS; Nashan B; Christians U; Schottmann R; Wonigeit K; Sewing KF
    Arzneimittelforschung; 1990 Jan; 40(1):62-4. PubMed ID: 2340002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules.
    Browne BJ; Jordan S; Welsh MS; Van Buren C; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):2959-60. PubMed ID: 7940934
    [No Abstract]   [Full Text] [Related]  

  • 17. The preparation and evaluation of a tablet dosage form of cyclosporine in dogs.
    Abdallah HY; Mayersohn M
    Pharm Res; 1991 Apr; 8(4):518-22. PubMed ID: 1871050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption profiles of renal allograft recipients receiving oral doses of cyclosporine: a pharmacokinetic study.
    Phillips TM; Karmi SA; Frantz SC; Henriques HF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):457-61. PubMed ID: 3284090
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant immunosuppressive and antibiotic therapy--reduction of cyclosporine A blood levels due to treatment with imipenem/cilastatin.
    Mraz W; Sido B; Knedel M; Hammer C
    Transplant Proc; 1987 Oct; 19(5):4017-20. PubMed ID: 3478881
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.